| abstract |
The invention relates to the use of polysubstituted indan-1-ol systems and t he physiologically acceptable salts and physiologically functional derivatives thereof for producing drugs used in the prophylaxis or treatment of obesity. The invention relates to the use of the compounds of formula (I), wherein th e groups are defined as indicated, and to the physiologically acceptable salts and physiologically functional derivatives thereof for producing a drug used in the prophylaxis or treatment of obesity. |